ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer"
Clinical trial NCT07381764 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07381764
- Sponsor
- Gruppo Oncologico Italia Meridionale
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-30
- Primary completion
- 2031-03-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.